Olivia Crayne is the Trial Management Director at Johnson & Johnson, a role they began in 2024. Previously, they served as the Director and Global Program Lead for COVID Vaccines at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2021 to 2024. Olivia's extensive experience includes positions such as Director of Clinical Operations at Seqirus from 2014 to 2021, DOCS Consultant Study Manager at bioCSL from 2014 to 2016, and Clinical Project Manager at Crayne Consulting from 2009 to 2014. Earlier in their career, they held the position of Director at GlaxoSmithKline Biologicals from 1988 to 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices